TOP1 Human

DNA Topoisomerase-I Human Recombinant
Shipped with Ice Packs
In Stock

Description

Structure and Mechanism

TOP1 consists of four domains:

  • N-terminal domain (1–213): Variable and unstructured, involved in protein interactions .

  • Core domain (214–635): Contains the capping (CAP) and catalytic (CAT) modules that entrap DNA .

  • Linker domain (636–712): Flexible region connecting the core to the C-terminal domain .

  • C-terminal domain (713–765): Houses the catalytic tyrosine residue (Y723) for DNA cleavage .

Catalytic Cycle:

  1. TOP1 binds supercoiled DNA, forming a toroidal structure .

  2. It cleaves one DNA strand, enabling rotation to relieve torsional stress .

  3. Re-ligation restores DNA integrity. Aborted reactions leave TOP1 covalently linked to DNA (TOP1cc), causing toxic lesions .

DNA Replication and Transcription

  • Resolves supercoils ahead of replication forks and RNA polymerase II (RNAPII) during transcription .

  • Prevents transcription-replication conflicts (TRCs) that lead to R loops and double-strand breaks (DSBs) .

Chromatin Dynamics

  • Facilitates chromatin loop formation and topologically associating domain (TAD) organization .

Cancer Therapy

TOP1 is a primary target for anticancer drugs like camptothecin, topotecan, and irinotecan . These inhibitors stabilize TOP1cc, converting transient DNA breaks into lethal DSBs during replication .

TOP1-Targeted DrugsMechanismClinical Use
Camptothecin derivativesStabilize TOP1ccColorectal, ovarian cancers
IndenoisoquinolinesIntercalate DNA-TOP1 complexExperimental therapies

Neurological and Genetic Disorders

  • Autism spectrum disorders: TOP1 regulates transcriptional elongation at long genes implicated in neurodevelopment .

  • Spinocerebellar ataxia (SCAN1): Mutations in TOP1 repair enzyme TDP1 cause neurodegeneration .

Genome Instability

  • TOP1ccs induce R loops and micronuclei, particularly during early S phase, exacerbating genomic instability in cancer cells .

  • RNase H1 overexpression mitigates TOP1cc-induced micronuclei, suggesting therapeutic strategies .

Mitochondrial TOP1 (TOP1mt)

  • A mitochondrial isoform (52% identity with nuclear TOP1) maintains mitochondrial DNA integrity .

  • Dysregulation linked to metabolic disorders and chemotherapy resistance .

Emerging Therapeutic Strategies

  • TOP1 suppressors: Compounds like LMP744 disrupt TOP1-DNA binding, reducing toxicity in sepsis models .

  • SUMOylation: Post-translational modifications regulate TOP1 activity at transcriptionally active regions, limiting DNA damage .

Future Directions

  • Targeting TOP1 in KRAS-mutant cancers, where TOP1 overexpression correlates with poor survival .

  • Developing inhibitors that avoid off-target effects in non-cancer cells .

Product Specs

Introduction
DNA topoisomerase I, a crucial nuclear enzyme, regulates DNA supercoiling, enabling proper DNA replication and transcription. It serves as the target antigen for Scl-70 autoantibodies, specific markers for Scleroderma, particularly in patients with diffuse skin involvement and pulmonary fibrosis. Human DNA topoisomerase I is initially synthesized as a 100 kDa protein, undergoing proteolytic processing to a 70 kDa form, hence the name Scl-70 antigen.
Description
Recombinant Human DNA Topoisomerase-I, produced in SF9 cells, is a glycosylated polypeptide chain with a molecular weight of 102 kDa. Featuring a -6xHis tag, TOP1 is purified using proprietary chromatographic techniques.
Physical Appearance
Clear, sterile-filtered solution.
Formulation
TOP1 is supplied in 16mM HEPES buffer (pH 7.5), containing 400mM sodium chloride and 20% glycerol.
Purity
Purity exceeds 95% as determined by SDS-PAGE.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended periods, store frozen at -20°C. Minimize repeated freeze-thaw cycles.
Synonyms
DNA topoisomerase 1, EC 5.99.1.2, DNA topoisomerase I, TOP1, Scl-70.
Source
Sf9 insect cells.

Q&A

What is human DNA topoisomerase I (TOP1) and what is its primary function?

Human TOP1 is a monomeric enzyme that resolves topological problems in DNA by transiently cleaving one strand of the DNA duplex. The enzyme introduces a single-strand break via transesterification at a target site, forming a DNA-(3'-phosphotyrosyl)-enzyme intermediate and releasing a 5'-OH DNA strand . This action allows the free DNA strand to rotate around the intact strand, relieving torsional stress that accumulates during processes like replication and transcription.

Methodologically, researchers studying TOP1's basic function should employ:

  • In vitro DNA relaxation assays using supercoiled plasmid DNA

  • Cleavage complex detection methods

  • Cellular assays measuring the consequences of TOP1 inhibition or depletion

How does TOP1 differ from other topoisomerases in the human genome?

TOP1 differs from other human topoisomerases in several key aspects:

FeatureHuman TOP1Human TOP2Human Mitochondrial TOP1 (top1mt)
StructureMonomericDimericMonomeric with mitochondrial targeting sequence
DNA cleavageSingle-strandDouble-strandSingle-strand
ATP requirementNoYesNo
Subcellular localizationNuclearNuclearMitochondrial
GeneTOP1TOP2A/TOP2BTOP1MT

To study these differences experimentally, researchers should:

  • Use specific inhibitors (camptothecins for TOP1, etoposide for TOP2)

  • Generate specific knockdown models for each enzyme

  • Employ subcellular fractionation techniques to isolate mitochondrial versus nuclear topoisomerase activities

What are the known structural domains of human TOP1 and their functions?

Human TOP1 comprises several functional domains that contribute to its catalytic activity:

  • N-terminal domain: Contains nuclear localization signals and sites for protein-protein interactions

  • Core domain: Responsible for DNA binding and contains residues important for catalysis

  • Linker domain: Connects the core and C-terminal domains, allowing conformational flexibility

  • C-terminal domain: Contains the catalytic tyrosine residue (Tyr723) that forms the covalent bond with DNA

For structural studies of TOP1, researchers should consider:

  • X-ray crystallography of TOP1-DNA complexes with and without inhibitors

  • Site-directed mutagenesis of key residues to assess functional importance

  • Domain deletion/swapping experiments to determine domain-specific functions

What assays are available for measuring TOP1 activity and how should they be optimized?

Several complementary approaches can be used to measure TOP1 activity:

Assay TypePrincipleAdvantagesLimitations
Plasmid RelaxationElectrophoretic separation of supercoiled vs. relaxed DNASimple, quantitativeLow throughput
DNA CleavageDetection of covalent TOP1-DNA complexesDirectly measures cleavageRequires radiolabeling for sensitivity
ELISA-basedQuantitative detection of TOP1 proteinHigh throughput, sensitive to 0.37ng/mLMeasures protein, not activity
Fluorescence-basedReal-time monitoring using fluorescent substratesReal-time kinetics, no gel requiredSpecialized equipment needed

For optimal results, researchers should:

  • Include appropriate controls (positive, negative, and enzyme titration)

  • Standardize reaction conditions (buffer composition, temperature, DNA substrate quality)

  • Consider the intra-assay CV (reported as 4.5% for ELISA methods) and inter-assay CV (7.4%)

How can TOP1 depletion models be effectively generated and validated?

Creating reliable TOP1 depletion models requires careful consideration of TOP1's essential nature:

  • RNAi approaches: Stable expression of siRNA targeting TOP1 has successfully created cell lines with ~5-fold reduction in TOP1 levels (e.g., HCT116-siTop1 and MCF-7-siTop1) .

  • Validation requirements:

    • Western blot confirmation of protein reduction

    • TOP1 activity assays to confirm functional depletion

    • Monitoring compensatory mechanisms (e.g., TOP2α upregulation)

    • Genomic instability assessment (chromosomal aberrations, γ-H2AX foci)

  • Phenotypic characterization:

    • Nucleolar and rDNA alterations

    • Replication defects

    • Transcriptional changes

    • Altered sensitivity to various anticancer agents

How does TOP1 contribute to genomic instability and cancer development?

TOP1's role in genomic stability has been demonstrated through multiple lines of evidence:

  • Stable TOP1-depleted cell lines (HCT116-siTop1 and MCF-7-siTop1) exhibit:

    • Chromosomal aberrations

    • Histone γ-H2AX foci associated with replication defects

    • rDNA and nucleolar alterations

    • Increased nuclear volume

These observations suggest that proper TOP1 function is critical for maintaining genomic integrity, and its dysregulation may contribute to cancer development through increased mutation rates and chromosomal instability.

Research strategies to study this connection include:

  • Long-term culture of TOP1-depleted cells to track accumulation of mutations

  • Analysis of TOP1 status in precancerous lesions versus advanced tumors

  • Correlation of TOP1 activity with genomic instability markers in patient samples

What is the mechanism of action of camptothecin (CPT) and other TOP1 inhibitors?

Camptothecin (CPT) is a plant alkaloid that specifically targets TOP1 through a well-characterized mechanism:

  • CPT binds to the TOP1-DNA complex after the enzyme has cleaved one DNA strand

  • It prevents the religation step, stabilizing the covalent TOP1-DNA complex

  • These stabilized complexes collide with advancing replication forks, creating DNA double-strand breaks

  • The resulting DNA damage rapidly blocks both DNA and RNA synthesis

Beyond CPT, various natural compounds interact with TOP1 at different stages of its catalytic cycle:

  • Terpenoids, flavonoids, stilbenes, and fatty acids can interfere with binding, cleavage, rotation, or religation processes

  • These compounds offer potential leads for developing new TOP1-targeting therapeutics

Methodologically, researchers studying TOP1 inhibitors should:

  • Employ multiple assay types to characterize inhibition mechanisms

  • Test compounds in both biochemical and cellular assays

  • Determine structure-activity relationships

  • Assess specificity through comparison with effects on other topoisomerases

How should researchers design experiments to identify non-canonical functions of TOP1?

TOP1 exhibits numerous non-canonical functions beyond its enzymatic DNA nicking-closing activity. To investigate these functions:

  • Experimental approaches:

    • Generate catalytically inactive TOP1 mutants to separate enzymatic from structural roles

    • Perform TOP1 protein interaction studies (co-IP, proximity labeling)

    • Conduct genome-wide transcription profiling (as demonstrated in siTop1 cells)

    • Use pharmacological profiling with various anticancer agents

  • Case study: TOP1 regulation of asparagine synthetase (ASNS) expression

    • TOP1 depletion reduced ASNS expression

    • TOP1 complementation increased ASNS expression

    • siTop1 cells showed hypersensitivity to L-asparaginase

This demonstrates how researchers can identify gene-specific transcriptional regulation by TOP1 through a combination of genomic and functional approaches.

What controls are essential when studying TOP1 function in human cells?

Proper experimental design for TOP1 research requires rigorous controls:

Control TypeExamplesPurpose
Expression controlsWild-type cells, complemented knockdown cells, catalytically inactive mutantsDistinguish enzymatic from structural functions
Treatment controlsVehicle controls, time-matched controls, concentration seriesEnsure specificity of observed effects
Validation controlsMultiple siRNA sequences, rescue experiments, cross-cell line validationRule out off-target effects
Compensation controlsTOP2α activity measurements, DNA damage response monitoringAccount for cellular adaptations

Researchers should be particularly aware that TOP2α compensates for TOP1 deficiency in stable knockdown lines , which may confound interpretation of results if not properly accounted for.

How can researchers avoid common mistakes when analyzing TOP1 experimental data?

Several common pitfalls affect TOP1 research data interpretation:

  • Ignoring compensatory mechanisms: TOP2α upregulation in TOP1-depleted cells can mask phenotypes .

  • Failing to distinguish direct from indirect effects: Effects observed after TOP1 inhibition may be several steps removed from TOP1's direct action.

  • Overlooking timing considerations: Acute versus chronic TOP1 depletion can yield different phenotypes.

  • Data inconsistencies: When contradictory results emerge across experimental systems, researchers must systematically evaluate:

    • Cell type differences

    • Experimental methodologies

    • Extent of TOP1 inhibition/depletion

    • Presence of replication stress

  • Inappropriate statistical analysis: Given the complex nature of TOP1 function, researchers should:

    • Apply appropriate statistical tests based on data distribution

    • Consider biological (not just statistical) significance

    • Avoid data fishing (running multiple tests to find significance)

    • Account for multiple hypothesis testing

How should researchers interpret changes in TOP1 expression across different datasets?

When comparing TOP1 expression or activity across different datasets:

  • Standardization considerations:

    • Normalize to appropriate housekeeping genes/proteins

    • Account for cell proliferation rates (highly proliferative cells typically have elevated TOP1)

    • Consider post-translational modifications that may affect activity

  • Context-dependent interpretation:

    • TOP1 changes may reflect adaptation to cellular stress

    • Expression changes may not correlate with activity changes

    • Subcellular localization is as important as total expression

  • Integration with highly cited research:

    • Compare findings with published highly cited research

    • Consider whether observed changes fall within expected ranges

    • Evaluate consistency with known TOP1 biology

What are emerging techniques for studying TOP1 dynamics in living cells?

Advanced technologies are transforming TOP1 research in living cells:

  • Live-cell imaging approaches:

    • FRAP (Fluorescence Recovery After Photobleaching) to study TOP1 mobility

    • FRET-based sensors to detect TOP1-DNA interactions

    • GFP-tagged TOP1mt for mitochondrial TOP1 localization studies

  • Single-molecule techniques:

    • Optical/magnetic tweezers to study TOP1-mediated DNA relaxation in real-time

    • Super-resolution microscopy to visualize TOP1 clustering at specific genomic sites

  • Genomic approaches:

    • TOP1 ChIP-seq to map genomic binding sites

    • TOP1cc sequencing to identify preferred cleavage sites

    • Integration with transcriptome data to correlate TOP1 activity with gene expression

Researchers adopting these techniques should carefully validate them against established biochemical assays and consider both their advantages and limitations when interpreting results.

How can contradictory findings about TOP1 function be reconciled across different experimental systems?

When faced with contradictory TOP1 findings:

  • Systematic comparison approach:

    • Create a comprehensive table of experimental conditions

    • Identify key variables that differ between studies

    • Design targeted experiments to test specific hypotheses about discrepancies

  • Integrated model development:

    • Formulate models that can accommodate seemingly contradictory observations

    • Test predictions of these models in multiple systems

    • Refine models based on new experimental data

  • Collaborative resolution:

    • Establish collaborations between laboratories with divergent findings

    • Implement standardized protocols and reagents

    • Perform blinded cross-validation studies

Product Science Overview

Structure and Function

TOP1 is a nuclear enzyme that plays a vital role in maintaining the supercoiling and torsional tension of DNA. It achieves this by transiently cleaving and rejoining one strand of the DNA duplex. The enzyme introduces a single-strand break via a transesterification reaction at a target site in the DNA. This allows the free DNA strand to rotate around the intact phosphodiester bond on the opposing strand, thereby removing DNA supercoils .

The enzyme’s catalytic activity involves the formation of a DNA-(3’-phosphotyrosyl)-enzyme intermediate, which is crucial for the relaxation of supercoiled DNA molecules . This process is essential for normal DNA replication and transcription, as it prevents the formation of knots and tangles in the DNA that could otherwise impede these processes .

Biological Importance

TOP1 is essential for normal cellular development and transcriptional regulation. It is involved in the circadian transcription of the core circadian clock component BMAL1 by altering the chromatin structure around the ROR response elements (ROREs) on the BMAL1 promoter . Additionally, TOP1 regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells .

Variants in the TOP1 gene have been associated with various diseases, including hematologic cancers and spinocerebellar ataxia . The enzyme is also a target antigen for Scl-70 autoantibodies, which are associated with systemic sclerosis .

Recombinant TOP1

Recombinant DNA Topoisomerase-I is produced using recombinant DNA technology, which involves inserting the human TOP1 gene into a suitable expression system, such as bacteria or yeast. This allows for the large-scale production of the enzyme for research and therapeutic purposes .

Recombinant TOP1 is used in various biochemical assays to study its function and interactions with other molecules. It is also employed in drug discovery efforts aimed at identifying inhibitors of TOP1, which could be potential therapeutic agents for treating cancers and viral infections .

Clinical and Research Applications

TOP1 inhibitors, such as camptothecin and its derivatives, are used as chemotherapeutic agents due to their ability to stabilize the TOP1-DNA complex, leading to DNA damage and cell death in rapidly dividing cancer cells . Additionally, research has shown that TOP1 can repress HIV-1 promoter activity through its interaction with a guanine quadruplex present in the LTR sequence, offering new perspectives for anti-viral strategies .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.